I am a Biotechnologist specialized in Molecular Genetics.From 2016 to 2024, I have been an integral part of a Research Laboratory, focusing on the evaluation of a drug for the treatment of Hemolytic Uremic Syndrome. My work involved designing and executing preclinical studies using cell cultures and animal models treated with Shiga toxin.Recently, I have expanded my expertise by joining a startup focused on molecular and cellular therapy, where I am involved in research and development of oncolytic adenoviruses. This new role has further enriched my skills in innovative therapeutic approaches and cutting-edge biotechnology.Throughout my career, I have honed my skills in objectively communicating and disseminating scientific information and clinical data. My role required meticulous attention to detail, innovative problem-solving, and a collaborative approach to research.My aspiration is to continue contributing to advancements in human health through dedicated research and development. I am eager to embrace new challenges that offer professional growth and personal fulfillment. I am a responsible and committed individual, with a blend of technical expertise and interpersonal skills, always enthusiastic about learning and self-improvement.